Research notes

The technical conviction delivery idea says the stock has seen a weekly consolidation breakout with base shifting higher and RSI positively placed, recommending buy at CMP ₹1,771 with SL ₹1,717 for a one-week duration.

The note reports JSW Cement will absorb listed subsidiary Shiva Cement to form a unified platform with synergies.

The note reports Shiva Cement will merge into JSW Cement, with Shiva shareholders receiving 5 JSW Cement shares for every 41 Shiva shares.

The velocity idea says oral Wegovy could raise peptide API needs ~73x per patient and that Proclamation 11020 gives India a 0% tariff rate on specialty drug classes, with a 21% earnings CAGR expected over FY26-28; CMP ₹9,540, SL ₹8,870.

The note says Trent's 2QFY27 standalone revenue grew 22.5% YoY with 30 net store adds to 1,342 fashion stores, and models FY26-29E revenue/pre-IND AS EBITDA/Adj. PAT CAGR of 21%/26%/19%, implying 46% upside from CMP INR2,580; separately the derivatives section lists a Trent 2600 PE buy idea on short buildup.

The initiating coverage section says Molbio's Truenat point-of-care molecular platform, with 12,500+ devices across 90+ countries and 43 assays, plus digital pathology expansion, should drive an estimated 23% revenue CAGR and 50% PAT CAGR over FY26-29, with 19% upside from CMP INR1,503.

The note says mills have raised long product prices by INR1,500-2,000/ton, flat steel by INR800-2,000/ton and alloy steel round bars by INR2,000-2,500/ton from 1 Oct'26, tagging the view as Positive.

The note says IndusInd's net advances grew 11.2% YoY beating estimates while deposits rose 10.1% YoY missing estimates, with CASA at 28.0% and FCNR(B) mobilisation of USD3.51b, and tags the view as Positive.

The note says Axis Bank's 2QFY27 gross advances grew 22.7% YoY beating estimates while deposits rose 20.7% YoY missing estimates, with CASA mix at 36.5% and CD ratio at 95.4%, and tags the view as Positive.

The note says Kotak's 2QFY27 net advances grew 24.7% YoY and deposits 23.2% YoY, both above estimates aided by FCNR(B) flows, though CASA fell to 38.2%, and tags the view as Positive.

The report's intraday quant strategy gives a MAZDOCK Sell idea at close price 2076 with SL 2097 and target 2055.

The report's intraday quant strategy gives an IREDA Sell idea at close price 108.9 with SL 110 and target 107.9.

The report separately lists a derivatives 2600 PE option buy on Trent in the buying range 97-98 with SL 88 and target 116, citing Short Buildup.

The report lists a 1200 PE option buy on Dr Reddy's in the buying range 30-31 with SL 27 and target 37, citing Short Buildup.

The report lists a 1440 PE option buy on Prestige in the buying range 43-44 with SL 39 and target 52, citing Short Buildup.

The report lists a 4750 CE option buy on HAL in the buying range 81-82 with SL 68 and target 108, citing Short Covering.

The report lists a 1120 CE option buy on PNB Housing in the buying range 30-31 with SL 27 and target 37, citing a Long Buildup.

The report flags a futures SELL idea (27th Oct) on GAIL at CMP 168, citing a range breakdown, trading below the 200 DEMA and a bearish candle, with resistance at 173.

The report notes a Hammer candle on the daily chart for Bharat Electronics at CMP 385, with immediate support at 373 and momentum building above 387.

The report gives a 1-week technical BUY call on LG Electronics India at CMP ₹1771 with SL ₹1717 and target ₹1879, citing a consolidation breakout and positive RSI.

The report lists Syrma SGS Tech as a Focus Investment Idea with a Buy rating, CMP Rs 1,700 and target Rs 2,000, implying 18% upside over 1 year.

The report lists Emcure Pharma as a Focus Investment Idea with a Buy rating, CMP Rs 1,937 and target Rs 2,300, implying 19% upside over 1 year.

The report lists Adani Ports as a Focus Investment Idea with a Buy rating, CMP Rs 1,774 and target Rs 2,130, implying 20% upside over 1 year.

The report lists SPR Auto Technologies as a Focus Investment Idea with a Buy rating, CMP Rs 4,399 and target Rs 6,150, implying 40% upside over 1 year.

The report lists Eternal as a Focus Investment Idea with a Buy rating, CMP Rs 321 and target Rs 430, implying 34% upside over 1 year.